Nutrition and late-life depression: Etiological considerations

Aging Health

Volumn 6, Issue 1, 2010, Pages 133-143

  Payne, Martha E ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain lesion; Depression; Folate; Omega 3; Serotonin; Vascular

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; OMEGA 3 FATTY ACID;

DEPRESSION; DIET; DISEASE ASSOCIATION; FATTY ACID METABOLISM; HUMAN; MENTAL DISEASE; NUTRITION; OBESITY; PREVALENCE; REVIEW; VASCULAR DISEASE;

EID: 77949642075     PISSN: 1745509X     EISSN: 17455103     Source Type: Journal    
DOI: 10.2217/ahe.09.90     Document Type: Review

References (102)

1. WHO: The World Health Report 2001. Mental Health: New Understanding, New Hope. World Health Organization, Geneva, Switzerland (2001).
2. Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Murray CJL, Lopez AD (Eds). Harvard University Press, MA, USA (1996).
3. Steffens DC, Skoog I, Norton MC et al.: Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch. Gen. Psychiatry 57(6), 601-607 (2000).
4. Roberts RE, Kaplan GA, Shema SJ, Strawbridge WJ: Prevalence and correlates of depression in an aging cohort: the Alameda County Study. J. Gerontol. B Psychol. Sci. Soc. Sci. 52(5), S252-S258 (1997).
5. Unutzer J, Patrick DL, Simon G et al.: Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study. JAMA 277(20), 1618-1623 (1997).
6. Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML: Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch. Intern. Med. 160(9), 1261-1268 (2000).
7. Hippisley-Cox J, Fielding K, Pringle M: Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ 316(7146), 1714-1719 (1998).
8. Mussolino ME: Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep. 120(1), 71-75 (2005).
9. Baldwin RC, Tomenson B: Depression in later life. A comparison of symptoms and risk factors in early and late onset scases. Br. J. Psychiatry 167(5), 649-652 (1995).
10. Steffens DC, MacFall JR, Payne ME, Welsh-Bohmer KA, Krishnan KR: Grey-matter lesions and dementia. Lancet 356(9242), 1686-1687 (2000).
11. Steffens DC, Plassman BL, Helms MJ, Welsh-Bohmer KA, Saunders AM, Breitner JC: A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol. Psychiatry 41(8), 851-856 (1997).
12. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (1994).
13. Kessler RC, Berglund P, Demler O et al.: The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23), 3095-3105 (2003).
14. Mulder RT, Frampton CM, Luty SE, Joyce PR: Eighteen months of drug treatment for depression: predicting relapse and recovery. J. Affect. Disord. 114(1-3), 263-270 (2009).
15. Thomas AJ, O'Brien JT, Davis S et al.: Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. Arch. Gen. Psychiatry 59(9), 785-792 (2002).
16. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am. J. Psychiatry 154(4), 497-501 (1997).
17. Conway CR, Steffens DC: Geriatric depression: further evidence for the 'vascular depression' hypothesis. Curr. Opin. Psychiatry 12, 463-470 (1999).
18. Krishnan KR, McDonald WM: Arteriosclerotic depression. Med. Hypotheses 44(2), 111-115 (1995).
19. Gonzalez MB, Snyderman TB, Colket JT et al.: Depression in patients with coronary artery disease. Depression 4(2), 57-62 (1996).
20. Goodnick PJ, Henry JH, Buki VM: Treatment of depression in patients with diabetes mellitus. J. Clin. Psychiatry 56(4), 128-136 (1995).
21. Aromaa A, Raitasalo R, Reunanen A et al.: Depression and cardiovascular diseases. Acta Psychiatr. Scand. Suppl. 377, 77-82 (1994).
22. Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 91(4), 999-1005 (1995).
23. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M: 'Vascular depression' hypothesis. Arch. Gen. Psychiatry 54(10), 915-922 (1997).
24. Paul RT, McDonnell AP, Kelly CB: Folic acid: neurochemistry, metabolism and relationship to depression. Hum. Psychopharmacol. 19(7), 477-488 (2004).
25. Payne ME, Haines PS, Chambless LE, Anderson JJB, Steffens DC: Food group intake and brain lesions in late-life vascular depression. Int. Psychogeriatr. 19(2), 295-305 (2007).
26. Sinclair AJ, Begg D, Mathai M, Weisinger RS: Omega 3 fatty acids and the brain: review of studies in depression. Asia Pac. J. Clin. Nutr. 16(Suppl. 1), 391-397 (2007).
27. Basic Neurochemistry. Molecular, Cellular, and Medical Aspects, Seventh Edition. Siegel GJ, Albers RW, Brady S (Eds). Elsevier Academic Press, Burlington, MA, USA (2006).
28. National Academy of Sciences, Institute of Medicine, Food and Nutrition Board: Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press, Washington, DC, USA (1998).
29. Botez MI, Young SN, Bachevalier J, Gauthier S: Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature 278(5700), 182-183 (1979).
30. Hunter R, Jones M, Jones TG, Matthews DM: Serum B12 and folate concentrations in mental patients. Brit. J. Psychiatry 113, 1291-1295 (1967).
31. Ghadirian AM, Ananth J, Engelsmann F: Folic acid deficiency and depression. Psychosomatics 21(11), 926-929 (1980).
32. Abou-Saleh MT, Coppen A: The biology of folate in depression: implications for nutritional hypotheses of the psychoses. J. Psychiatr. Res. 20(2), 91-101 (1986).
33. Bell IR, Edman JS, Marby DW et al.: Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol. Psychiatry 27(2), 125-137 (1990).
34. Levitt AJ, Joffe RT: Folate, B12, and life course of depressive illness. Biol. Psychiatry 25(7), 867-872 (1989).
35. Botez MI, Young SN, Bachevalier J, Gauthier S: Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann. Neurol. 12(5), 479-484 (1982).
36. Bottiglieri T, Hyland K, Laundy M et al.: Enhancement of recovery from psychiatric illness by methylfolate. Lancet 336(8730), 1579-1580 (1990).
37. Morris MS, Fava M, Jacques PF, Selhub J, Rosenberg IH: Depression and folate status in the US Population. Psychother. Psychosom. 72(2), 80-87 (2003).
38. Sachdev PS, Parslow RA, Lux O et al.: Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol. Med. 35(4), 529-538 (2005).
39. Ramos MI, Allen LH, Haan MN, Green R, Miller JW: Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. Am. J. Clin. Nutr. 80(4), 1024-1028 (2004).
40. Dimopoulos N, Piperi C, Salonicioti A et al.: Correlation of folate, vitamin B(12) and homocysteine plasma levels with depression in an elderly Greek population. Clin. Biochem. 40(9-10), 604-608 (2007).
41. Eussen SJ, Ferry M, Hininger I, Haller J, Matthys C, Dirren H: Five year changes in mental health and associations with vitamin B12/folate status of elderly Europeans. J. Nutr. Health Aging 6(1), 43-50 (2002).
42. Lindeman RD, Romero LJ, Koehler KM et al.: Serum vitamin B12, C and folate concentrations in the New Mexico elder health survey: correlations with cognitive and affective functions. J. Am. Coll. Nutr. 19(1), 68-76 (2000).
43. Penninx BW, Guralnik JM, Ferrucci L, Fried LP, Allen RH, Stabler SP: Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study. Am. J. Psychiatry 157(5), 715-721 (2000).
44. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM: Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch. Gen. Psychiatry 60(6), 618-626 (2003).
45. Tiemeier H, van Tuijl HR, Hofman A, Meijer J, Kiliaan AJ, Breteler MM: Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am. J. Psychiatry 159(12), 2099-2101 (2002).
46. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Yoon JS: Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br. J. Psychiatry 192, 268-274 (2008).
47. Payne ME, Jamerson BD, Potocky CF, Ashley-Koch AE, Speer MC, Steffens DC: Natural food folate and late-life depression. J. Nutr. Elder. 28, 348-358 (2009).
48. Kamphuis MH, Geerlings MI, Grobbee DE, Kromhout D: Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur. J. Clin. Nutr. 62(8), 939-945 (2008).
49. Murakami K, Mizoue T, Sasaki S et al.: Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults. Nutrition 24(2), 140-147 (2008).
50. Tolmunen T, Hintikka J, Ruusunen A et al.: Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother. Psychosom. 73(6), 334-339 (2004).
51. Forti P, Rietti E, Pisacane N et al.: Blood homocysteine and risk of depression in the elderly. Arch. Gerontol. Geriatr. DOI: 10.1016/j.archger.2009. 06.009 (2009) (Epub ahead of print).
52. Almeida OP, Lautenschlager N, Flicker L et al.: Association between homocysteine, depression, and cognitive function in community-dwelling older women from Australia. J. Am. Geriatr. Soc. 52(2), 327-328 (2004).
53. Lewis SJ, Lawlor DA, Davey Smith G et al.: The thermolabile variant of MTHFR is associated with depression in the British Women's Heart and Health Study and a meta-analysis. Mol. Psychiatry 11(4), 352-360 (2006).
54. Kelly CB, McDonnell AP, Johnston TG et al.: The MTHFR C677T polymorphism is associated with depressive episodes in patients from Northern Ireland. J. Psychopharmacol. 18(4), 567-571 (2004).
55. Slopien R, Jasniewicz K, Meczekalski B, Warenik-Szymankiewicz A, Lianeri M, Jagodzinski PP: Polymorphic variants of genes encoding MTHFR, MTR, and MTHFD1 and the risk of depression in postmenopausal women in Poland. Maturitas 61(3), 252-255 (2008).
56. Reif A, Pfuhlmann B, Lesch KP: Homocysteinemia as well as methylenetetrahydrofolate reductase polymorphism are associated with affective psychoses. Prog. Neuropsychopharmacol. Biol. Psychiatry 29(7), 1162-1168 (2005).
57. Gallagher ML: Vitamins. In: Krause's Food, Nutrition, and Diet Therapy. Mahan LK, Escott-Stump S (Eds). Saunders, PA, USA 75-119 (2004).
58. Lindenbaum J, Healton EB, Savage DG et al.: Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318(26), 1720-1728 (1988).
59. Hutto BR: Folate and cobalamin in psychiatric illness. Compr. Psychiatry 38(6), 305-314 (1997).
60. Payne ME, Hybels CF, Bales CW, Steffens DC: Vascular nutritional correlates of late-life depression. Am. J. Geriatr. Psychiatry 14, 787-795 (2006).
61. Merrill RM, Taylor P, Aldana SG: Coronary Health Improvement Project (CHIP) is associated with improved nutrient intake and decreased depression. Nutrition 24(4), 314-321 (2008).
62. Sanchez-Villegas A, Delgado-Rodriguez M, Alonso A et al.: Association of the Mediterranean dietary pattern with the incidence of depression: the Seguimiento Universidad de Navarra/University of Navarra follow-up (SUN) cohort. Arch. Gen. Psychiatry 66(10), 1090-1098 (2009).
63. Maes M, Christophe A, Delanghe J, Altamura C, Neels H, Meltzer HY: Lowered omega3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 85(3), 275-291 (1999).
64. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI: One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47(1), 172-180 (2006).
65. de la Presa Owens S, Innis SM: Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and a-linolenic acid deficient diet in formula-fed piglets. J. Nutr. 129(11), 2088-2093 (1999).
66. Innis SM, de La Presa Owens S: Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J. Nutr. 131(1), 118-122 (2001).
67. Hibbeln JR: Fish consumption and major depression. Lancet 351(9110), 1213 (1998).
68. Tanskanen A, Hibbeln JR, Hintikka J, Haatainen K, Honkalampi K, Viinamaki H: Fish consumption, depression, and suicidality in a general population. Arch. Gen. Psychiatry 58(5), 512-513 (2001).
69. Timonen M, Horrobin D, Jokelainen J, Laitinen J, Herva A, Rasanen P: Fish consumption and depression: the Northern Finland 1966 birth cohort study. J. Affect. Disord. 82(3), 447-452 (2004).
70. Kamphuis MH, Geerlings MI, Tijhuis MA, Kalmijn S, Grobbee DE, Kromhout D: Depression and cardiovascular mortality: a role for n-3 fatty acids? Am. J. Clin. Nutr. 84(6), 1513-1517 (2006).
71. Hakkarainen R, Partonen T, Haukka J, Virtamo J, Albanes D, Lonnqvist J: Is low dietary intake of omega-3 fatty acids associated with depression? Am. J. Psychiatry 161(3), 567-569 (2004).
72. Appleton KM, Peters TJ, Hayward RC et al.: Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association? Soc. Psychiatry Psychiatr. Epidemiol. 42(2), 100-104 (2007).
73. Jacka EN, Pasco JA, Henry MJ, Kotowicz MA, Nicholson GC, Berk M: Dietary omega-3 fatty acids and depression in a community sample. Nutr. Neurosci. 7(2), 101-106 (2004).
74. Mamalakis G, Jansen E, Cremers H, Kiriakakis M, Tsibinos G, Kafatos A: Depression and adipose and serum cholesteryl ester polyunsaturated fatty acids in the survivors of the seven countries study population of Crete. Eur. J. Clin. Nutr. 60(8), 1016-1023 (2006).
75. Schins A, Crijns HJ, Brummer RJ et al.: Altered omega-3 polyunsaturated fatty acid status in depressed post-myocardial infarction patients. Acta Psychiatr. Scand. 115(1), 35-40 (2007).
76. Feart C, Peuchant E, Letenneur L et al.: Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. Am. J. Clin. Nutr. 87(5), 1156-1162 (2008).
77. Hibbeln JR, Umhau JC, George DT, Salem N Jr: Do plasma polyunsaturates predict hostility and depression? World Rev. Nutr. Diet 82, 175-186 (1997).
78. Lidberg L, Tuck JR, Asberg M, Scalia-Tomba GP, Bertilsson L: Homicide, suicide and CSF 5-HIAA. Acta Psychiatr. Scand. 71(3), 230-236 (1985).
79. Samuelsson M, Jokinen J, Nordstrom AL, Nordstrom P: CSF 5-HIAA, suicide intent and hopelessness in the prediction of early suicide in male high-risk suicide attempters. Acta Psychiatr. Scand. 113(1), 44-47 (2006).
80. Adams PB, Lawson S, Sanigorski A, Sinclair AJ: Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31(Suppl.), S157-S161 (1996).
81. Morley JE, Mooradian AD, Silver AJ, Heber D, Alfin-Slater RB: Nutrition in the elderly. Ann. Intern. Med. 109(11), 890-904. (1988).
82. Kolasa KM, Mitchell JP, Jobe AC: Food behaviors of southern rural community-living elderly. Arch. Fam. Med. 4(10), 844-848 (1995).
83. Jorm AF, Korten AE, Christensen H, Jacomb PA, Rodgers B, Parslow RA: Association of obesity with anxiety, depression and emotional well-being: a community survey. Aust. NZ J. Public Health 27(4), 434-440 (2003).
84. Musante GJ, Costanzo PR, Friedman KE: The comorbidity of depression and eating dysregulation processes in a diet-seeking obese population: a matter of gender specificity. Int. J. Eat. Disord. 23(1), 65-75 (1998).
85. Ross CE: Overweight and depression. J. Health Soc. Behav. 35(1), 63-79 (1994).
86. Strawbridge WJ, Deleger S, Roberts RE, Kaplan GA: Physical activity reduces the risk of subsequent depression for older adults. Am. J. Epidemiol. 156(4), 328-334 (2002).
87. Jahng JW, Kim JG, Kim HJ, Kim BT, Kang DW, Lee JH: Chronic food restriction in young rats results in depression- and anxiety-like behaviors with decreased expression of serotonin reuptake transporter. Brain Res. 1150, 100-107 (2007).
88. Chandler-Laney PC, Castaneda E, Pritchett CE et al.: A history of caloric restriction induces neurochemical and behavioral changes in rats consistent with models of depression. Pharmacol. Biochem. Behav. 87(1), 104-114 (2007).
89. Patten SB: 'Diet pills' and major depression in the Canadian population. Can. J. Psychiatry 46(5), 438-440 (2001).
90. Li ZB, Ho SY, Chan WM et al.: Obesity and depressive symptoms in Chinese elderly. Int. J. Geriatr. Psychiatry 19(1), 68-74 (2004).
91. Ho RC, Niti M, Kua EH, Ng TP: Body mass index, waist circumference, waist-hip ratio and depressive symptoms in Chinese elderly: a population-based study. Int. J. Geriatr. Psychiatry 23(4), 401-408 (2008).
92. Simon GE, Ludman EJ, Linde JA et al.: Association between obesity and depression in middle-aged women. Gen. Hosp. Psychiatry 30(1), 32-39 (2008).
93. Ma J, Xiao L: Obesity and depression in US women: results from the 2005-2006 National Health and Nutritional Examination Survey. Obesity (Silver Spring) DOI: 10.1038/ oby.2009.213 (2009) (Epub ahead of print).
94. Kloiber S, Ising M, Reppermund S et al.: Overweight and obesity affect treatment response in major depression. Biol. Psychiatry 62(4), 321-326 (2007).
95. Murphy JM, Horton NJ, Burke JD Jr et al.: Obesity and weight gain in relation to depression: findings from the Stirling County Study. Int. J. Obes. (Lond.) 33(3), 335-341 (2009).
96. Crisp AH, McGuiness B: Jolly fat: relation between obesity and psychoneurosis in general population. BMJ 1(6000), 7-9 (1976).
97. Roberts RE, Deleger S, Strawbridge WJ, Kaplan GA: Prospective association between obesity and depression: evidence from the Alameda County Study. Int. J. Obes. Relat. Metab. Disord. 27(4), 514-521 (2003).
98. Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L: Obesity and metabolic syndrome increase the risk of incident depression in older men: the Health in Men Study. Am. J. Geriatr. Psychiatry 17(10), 889-898 (2009).
99. Steptoe A, Wardle J: Cardiovascular stress responsivity, body mass and abdominal adiposity. Int. J. Obes. (Lond.) 29(11), 1329-1337 (2005).
100. Thakore JH, Richards PJ, Reznek RH, Martin A, Dinan TG: Increased intra-abdominal fat deposition in patients with major depressive illness as measured by computed tomography. Biol. Psychiatry 41(11), 1140-1142 (1997).
101. Weber-Hamann B, Werner M, Hentschel F et al.: Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 31(3), 347-354 (2005).
102. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291(23), 2847-2850 (2004).